2023

20232023

31
Jan

Elvan Böke’s research group receives a 2-million-euro European Research Consolidator grant

19
Jan
This shows a cross-section of a mouse lung infected with Pseudonomas aeruginosa. The mouse was treated with a version of Mycoplasma pneumoniae that could not produce therapeutic molecules, resulting in severe pneumoniae. This is characterised by massive infiltration of inflammatory cells into the alveolar septa, resulting in loss of air in the alveoli. Credit: Rocco Mazzolini/CRG

Study showcases synthetic biology's potential in transforming treatment of human disease